AusPAR: Jardiance
Australian Public Assessment Report
Device/Product Name
Jardiance
Active ingredients
empagliflozin
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-05194-1-5
Submission Type
Extension of indication
Decision
Approved